NCT06803186

Brief Summary

The study will be conducted: To investigate the effect of high-power laser on myoelectrical activities of suboccipital muscles in patients with cervicogenic headache.

  • To investigate the effect of high-power laser on pain in patients with cervicogenic headache.
  • To investigate the effect of high-power laser on quality of life in patients with cervicogenic headache.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 31, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

January 31, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

February 4, 2025

Status Verified

January 1, 2025

Enrollment Period

3 months

First QC Date

January 27, 2025

Last Update Submit

January 31, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Myoelectrical activity of suboccipital muscle

    Needle electromyography (EMG, Micromed, made in Italy) is a definitive invasive technique that allows an objective evaluation of muscle activity. Activation pattern of the suboccipital muscle mainly the rectus capitis posterior muscles will be recorded and analyzed. The skin is cleaned with alcohol to reduce skin impedance. A Concentric needle is inserted in the rectus capitis posterior muscles, positioned caudad, at a point 1-2cm lateral to the midline at the level of the approximation of the posterior arch of C1. at approximately 80 degrees from an imaginary line drawn parallel to the surface of the skin in the mid-sagital plane. The patient performed extension delivering maximum voluntary contraction against therapist hand. Reference electrode is placed just above the middle of the spine of the right scapula or over the forehead. Data will be represented as interference patterns (graphics), analyzed and compared before and after the intervention for all participants in the study.

    6 weeks

  • Neck Disability Index (NDI)

    The NDI will be used to assess neck pain and quality of life for all participants before and after the treatment program. It is consisted of 10 items with six potential responses per item relating to pain severity, headache, attention, and various physical activities (lifting, personal care, recreation, work, driving, reading, and sleeping). Each item's score ranges from 0 to 5. The maximum possible total score is 50, which is translated to a percentage. Higher scores indicate a greater degree of impairment. The NDI has been demonstrated to be a valid, had stable psychometric characteristics and accurate questionnaire for people suffering from neck pain

    6 weeks

  • Quality of life (QoL) assessment

    The SF-36 questionnaire will be used to assess QoL for all participants before and after the end of the study program. It is a self-administered questionnaire containing 36 items which takes about five minutes to complete. It measures health on eight multi-item dimensions, covering physical functioning, role limitation due to physical health, bodily pain, general health perception, vitality, social functioning, role limitation due to emotional problems and perceived mental health. Each domain contains number of items. The answers to each question are extrapolated to a standardized set of answers, and the results are transferred to a scale of 0-100, where 0 represents the worst state of health measured, and 100 represents the best state of health measured. It has good validity and reliability and can be used as a general questionnaire to assess quality of life.

    6 weeks

Secondary Outcomes (2)

  • Pain intensity

    6 weeks

  • Headache impact test-6 (The HIT-6)

    6 weeks

Study Arms (2)

High power laser therapy and conventional physical therapy program

EXPERIMENTAL

The participants will receive high power laser therapy (HPLT) for 15 minutes in addition to a conventional physical therapy program (therapeutic exercise) for 45 minutes three a week for six weeks.

Device: High-power laser therapyOther: Conventional physical therapy program

Placebo high power laser therapy and conventional physical therapy program

ACTIVE COMPARATOR

The participants will receive placebo high power laser therapy (HPLT) for 15 minutes in addition to a conventional physical therapy program (therapeutic exercise) for 45 minutes three a week for six weeks.

Device: Placebo (PL) high power laserOther: Conventional physical therapy program

Interventions

High power laser therapy (HPLT) with a neodymium-yttrium aluminum garnet laser with a pulsating waveform produced by a ( Hilterapia device , ASA, Arcugnano, Vicenza, Italy). It will be set at the following parameters: Nd:YAG laser with pulsed emission (1064 nm), very high peak powers with average power 6 W, high levels of fluency (760 mJ/cm energy density), short pulse duration (250 μs), low frequency (10-40 Hz), and 5-cm probe diameter for 15 minutes. The scanning will be performed longitudinally \&transversely from the C3 to C7 posterior neck in the paraspinal region, upper back, inter-scapular area, trapezius, sternocleidomastoid muscles, and posterior \& lateral shoulder areas

High power laser therapy and conventional physical therapy program

laser probe scanning will be applied to the same areas as that applied in the HPLT procedure. PL will be applied while the lights of the device will be on, with no current flowing through the device. Placebo therapy will be applied at the same frequency as HPLT (Three sessions a week for six weeks for a total of 18 sessions; one session will be lasted 15 minutes).

Placebo high power laser therapy and conventional physical therapy program

A specific program of 45-min exercise of three sessions a week for six weeks for a total of 18 sessions. Corrective exercises will be performed initially by stretching exercises for(suboccipital, upper trapezeius, scalene, levator scapulae, sternocleidomastoid, pectoralis major/minor muscles) will be given four repetitions with 30 second hold. each with 3 seconds rest between each stretch Then, strengthening exercises will be performed initially in an isometric manner for weak muscles (deep cervical flexors, rhomboidus, and lower trapezeius muscles) will be done initially without weight and afterward by using Theraband and dumbells. All patients will be instructed to achieve three sets of 12 repetitions of the strengthening exercises (isometrics exercises) with 1 to 2 minutes rest in between each set. Contraction will be held for 5 seconds/repetitions. 10-20 repetitions for strengthening exercises and 3 sets of 30 repetitions for endurance exercise

High power laser therapy and conventional physical therapy programPlacebo high power laser therapy and conventional physical therapy program

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients suffering from cervicogenic headache based on international headache society "IHS" criteria for cervicogenic headache.
  • Unilateral cervical radiculopathy (Upper cervical C1 -C4).
  • Age ranged from 30 to 50 years.
  • Neck pain referring unilaterally to suboccipital region.
  • The pain and restriction in C1-C2 rotation by Cervical Flexion-Rotation Test (FRT )
  • Intensifying headache by manual pressure to upper cervical muscles and joints.
  • Experiencing headache at least once per week for the last 6 months.
  • Patients will be referred by neurological consultants.
  • Body mass index (18.5 - 29. 9 Kg/m2).
  • Moderate (45-74) to severe (75-100) neck pain on the visual analogue scale.

You may not qualify if:

  • Cervical myelopathy, cervical instability, cervical fracture cervical surgery with evidence of pyramidal, posterior column disorders.
  • History of any neurologic disease ( stroke, MS , cerebellar disorders , vestibular dysfunction and neuropathy )Pregnant or breastfeeding women
  • Other types of headaches (migraine - cluster headaches- tension headache)
  • Patients of systemic diseases such as rheumatoid arthritis
  • contraindication to high-power Laser such as:
  • Wounds or skin changes in the neck or shoulder region (such as psoriasis, scars, or burns).
  • Photosensitivity diagnosis.
  • Tumors of some type have been diagnosed in the last 5 years.
  • Presence of solar urticaria or adverse reactions to sunlight.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Karem Youssef Tawfik

Cairo, Egypt

Location

MeSH Terms

Conditions

Post-Traumatic Headache

Condition Hierarchy (Ancestors)

Headache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Shehab Khadrawy, Professor

    Al-Azhar University

    STUDY DIRECTOR
  • Asharaf A. Abdelmoneim, Professor

    Cairo University

    STUDY DIRECTOR
  • Abd El-Aleem A Attia, professor

    Cairo University

    STUDY CHAIR

Central Study Contacts

Ahmed K youssef, PHD

CONTACT

Mohamed H. Marzouk, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 27, 2025

First Posted

January 31, 2025

Study Start

January 31, 2025

Primary Completion

April 30, 2025

Study Completion

May 15, 2025

Last Updated

February 4, 2025

Record last verified: 2025-01

Locations